CRISPR Therapeutics AG (CRSP) Interest Expenses (2015 - 2026)

CRISPR Therapeutics AG (CRSP) posted Interest Expenses of $14.5 million for Q1 2026, up 7313.27% sequentially from $196000.0 in Q4 2025.

CRISPR Therapeutics AG (CRSP) Interest Expenses (2015 - 2026) Analysis & Trends

CRISPR Therapeutics AG has reported Interest Expenses for 12 years, with the latest figure at $14.5 million in Q1 2026.

Quarterly Interest Expenses changed N/A year-over-year to $14.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.5 million (up 606.03% YoY) and the FY2025 annual result came in at $42.3 million, up 46.02% from the prior year.
Interest Expenses rose to $14.5 million in Q1 2026 per CRSP's latest filing, from $196000.0 in the prior quarter.
Over five years, Interest Expenses peaked at $198.3 million in Q4 2022 and troughed at $106000.0 in Q3 2025.
A 5-year average of $27.3 million and a median of $10.0 million in 2023 frame the typical range for Interest Expenses.
The sharpest annual moves came in 2022 and 2025: Interest Expenses surged 2962.5% in 2022, then tumbled 98.6% in 2025.
Over 5 years, Interest Expenses stood at $198.3 million in 2022, then tumbled by 41.66% to $115.7 million in 2023, then slumped by 87.85% to $14.0 million in 2024, then sank by 98.6% to $196000.0 in 2025, then surged by 7313.27% to $14.5 million in 2026.
According to Business Quant data, Interest Expenses over the past three periods registered $14.5 million, $196000.0, and $106000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int Expense (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	439.40 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	52.50 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	2.70 Bn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	39.74 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	335,572.77
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	218.10 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	82.05 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	20.27 Mn
10	CRISPR Therapeutics AG	5.18 Bn	5.18 Bn	-	13.80 Mn

Download Data